Cargando…
Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient
Autores principales: | Chavarot, Nathalie, Burger, Carole, Aguilar, Claire, Scemla, Anne, Sberro-Soussan, Rebecca, Amrouche, Lucile, Leruez-Ville, Marianne, Martinez, Frank, Legendre, Christophe, Anglicheau, Dany, Zuber, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826029/ https://www.ncbi.nlm.nih.gov/pubmed/33518372 http://dx.doi.org/10.1016/j.kint.2020.12.027 |
Ejemplares similares
-
Decline and loss of anti–SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection
por: Chavarot, Nathalie, et al.
Publicado: (2021) -
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
por: Chavarot, Nathalie, et al.
Publicado: (2021) -
Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
por: Chavarot, Nathalie, et al.
Publicado: (2022) -
Conversion From Intravenous In-Hospital Belatacept Injection to Subcutaneous Abatacept Injection in Kidney Transplant Recipients During the First COVID-19 Stay-at-Home Order in France
por: Bertrand, Dominique, et al.
Publicado: (2023) -
COVID-19: A One-center Experience in Paris
por: Chavarot, Nathalie, et al.
Publicado: (2020)